Ładuje się......
Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia
The treatment of benign prostatic hyperplasia (BPH) has changed dramatically over the past 10 years. Phase 3 studies of the safety and effectiveness of α-blockers (eg, terazosin and doxazosin) and 5-α-reductase inhibitors (eg, finasteride) for the treatment of BPH began to appear in the literature i...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MedReviews, LLC
2003
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1502363/ https://ncbi.nlm.nih.gov/pubmed/16985967 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|